Antiviral agents: the road from scepticism to efficacy.
D000212:Acyclovir; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007659:Ketones / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D010746:Phosphonoacetic Acid / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D007659:Ketones; C020235:brivudine; D006147:Guanine; C020706:arildone; D007372:Interferons; D000547:Amantadine; D014740:Vidarabine; D001973:Bromodeoxyuridine; D010746:Phosphonoacetic Acid; D000212:Acyclovir